Company Filing History:
Years Active: 2018
Title: Mark David Rekhter: Innovator in Pharmaceutical Development
Introduction
Mark David Rekhter is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific health conditions. With a total of 2 patents to his name, Rekhter's work is recognized for its potential impact on human health.
Latest Patents
Among his latest patents is a triazolopyrazinone derivative that serves as a human PDE1 inhibitor. This invention provides a compound of Formula I that is useful for treating chronic kidney disease and diabetic kidney disease. The innovative nature of this compound highlights Rekhter's commitment to addressing critical health issues through scientific research.
Career Highlights
Mark David Rekhter is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to pharmaceutical innovation.
Collaborations
Rekhter has worked alongside esteemed colleagues such as Qing Shi and Cynthia Darshini Jesudason. These collaborations have fostered an environment of creativity and innovation, leading to advancements in the field of drug development.
Conclusion
Mark David Rekhter's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving health outcomes through scientific advancements.